Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kate F Byth

1PUBLICATIONS

10CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 29, 2020

AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-x<sub>L</sub>, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia.

Srividya B Balachander, Steven W Criscione, Kate F Byth

Pageof 1

Frequent Collaborators

1 joint publications

Justin Cidado

1 joint publications

Shenghua Wen

1 joint publications

Jeffrey W Tyner

1 joint publications

William McCoull

1 joint publications

Omid Tavana

1 joint publications

Mathew J Garnett

1 joint publications

Patricia Jaaks

1 joint publications

Elizabeth A Coker

1 joint publications

Gareth P Gregory

1 joint publications

Francis D Gibbons

Frequent Collaborators

1 joint publications

Justin Cidado

1 joint publications

Shenghua Wen

1 joint publications

Jeffrey W Tyner

1 joint publications

William McCoull

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

See more related videos

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

See more related videos